Table 4.

Descriptive statistics for antibiotic associated disability cases

		FQ AD		AZ/ST AD
		N = 264		N = 243
		Count	%	Count	%
Age	Mean (sd)	48.5 (8.2)		48.8 (8.7)
	Median	49		51
	Range	26–64		24–64
	18–29 years	5	1.9	6	2.5
	30–59 years	238	90.2	218	89.7
	> = 60 years	21	8.0	19	7.8
Gender	Female	146	55.3	152	62.6
	Male	118	44.7	91	37.4
Non-UTI Casesa	Total	164	62.1	207	85.2
	Female	73	44.5	122	58.9
	Male	91	55.5	85	41.1
Indication	Sinusitis	97	33.1	96	35.3
	Bronchitis	50	17.1	100	36.8
	Cystitis/UTI	100	34.1	36	13.2
	Sinusitis/bronchitis	15	5.1	9	3.3
	Bronchitis/UTI	2	0.7	2	0.7
Days to AE Onset	Mean (sd)	9.7 (7.1)		10.5 (7.8)
	Median	8		8
	Range	1–30		1–29
	1–2 days	41	15.5	38	15.6
	3–4 days	33	12.5	29	11.9
	5–10 days	88	33.3	77	31.7
	> 10 days	102	38.6	99	40.7
Days to Confirmatory Diagnosis	Mean (sd)	46.7 (16.0)		49.0 (16.0)
Range 30–90 days	Median	42		44

Abbreviations: AZ Azithromycin, FQ Fluoroquinolone, ST Sulfamethoxazole / Trimethoprim, UTI Urinary tract infection

^aThe count of Non-UTI cases includes indications for bronchitis and sinusitis. When these indications occurred in combination with UTI, they were included in this count